HM15211

Efocipegtrutide · Hanmi Pharmaceutical Company Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HM15211, covering 2025-11-19 to 2025-11-19. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects [Phase 2]